Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2005
11/02/2005CN1689556A Oral administered sustained release lozenge composition and its preparation method
11/02/2005CN1225464C Extraction technology of Hanbaicalein, medicinal composition and preparation technology of medicine
11/02/2005CN1225287C Stabilized radiopharmaceutical composition
11/02/2005CN1225284C Process for preparing poly lactic acid super microball carrying medicine
11/02/2005CN1225282C Medicine for treating prolapse of lumber intervertebral disc
11/02/2005CN1225280C Plaster for treating prolapse of intervertebral disc
11/02/2005CN1225276C Preparation method of red peony root injection
11/02/2005CN1225270C Medicine for treating atherosclerosis and its preparing method
11/02/2005CN1225268C 'Sanhuang' dripping pills and preparing method thereof
11/02/2005CN1225261C Spray for treating snore
11/02/2005CN1225252C Process for preparing composition comprising medicinal herb extract for preventing and treating arthritis and composition thereof
11/02/2005CN1225249C Antivirus medicine for raising immunity and its preparation method
11/02/2005CN1225248C Antineoplastic effect of a group of cycloart-one triterpene compound
11/02/2005CN1225247C Storage stable tretinoin and 4-hydroxy anisole contg. topical compsn.
11/02/2005CN1225246C Releasing improved pharmaceutical preparation containing amoxicillin
11/02/2005CN1225241C Method for preparing oral disintegrating tablet
11/02/2005CN1225240C Enteric coated particle preparation containing 2-[(4-methoxy-3-methyl)-2- pyridyl] methyl sulfenyl-5-(1H-pyrrole-1-radical)-1H-benzimidazole
11/02/2005CN1225239C Fimbriate orostachys herb suppository and its preparing process
11/02/2005CN1225230C High viscosity liquid controlled delivery system
11/02/2005CN1225217C Application of Acer truncatum extract as cigarette free radical scavenger and corresponding cigarette
11/02/2005CN1225198C Heat-clearing factor
11/01/2005US6960617 Mixing ethylenically-unsaturated monomer and multi-olefinic crosslinking agent; subjecting to polymerization conditions and foaming to form composite; combining at least one strengthening agent
11/01/2005US6960564 Echinocandin pharmaceutical formulations containing micelle-forming surfactants
11/01/2005US6960563 Spontaneous emulsions containing cyclosporine
11/01/2005US6960561 Polypeptide mixture containing preservative, surfactant and stabilizer
11/01/2005US6960560 Iron chelator delivery system
11/01/2005US6960469 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain
11/01/2005US6960357 Controlled release; drugs mixed with inert ingredients compressed into tablets
11/01/2005US6960356 tablet or capsule comprising a drug such as ciprofloxacin, acyclovir, diltiazem, ranitidine, or captopril, a gas generator, a swelling agent, a viscolyzing agent, and optional gel forming polymer; Controlled Gas Powered System; stomach retention
11/01/2005US6960355 Modified amino acid compounds useful in delivery of active agents
11/01/2005US6960353 Formulations for the transdermal administration of fenoldopam
11/01/2005US6960352 Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent
11/01/2005US6960351 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
11/01/2005US6960350 Comprises aliphatic/aromatic alcohol and aliphatic/aromatic aldehyde; synergism; for use in room, closet or shoe box
11/01/2005US6960346 Using citric acid esters or ethers
11/01/2005US6960341 Bifidobacteria and preparations containing them
11/01/2005US6960300 Process for preparing water soluble diterpenes and their applications
11/01/2005US6960256 Formation of small crystals
11/01/2005US6960251 Silica comprising at least two silica fractions, wherein said at least two silica fractions differ in value for surface area and oil absorption, in given ranges; good absorbency, low dust
11/01/2005CA2457029C Breath freshening film
11/01/2005CA2383351C Xanthine derivatives as selective antagonists of a2b adenosine receptors
11/01/2005CA2264852C Use of methylphenidate or a pharmaceutically acceptable salt thereof
11/01/2005CA2216371C Novel "burst-free" sustained release poly-(lactide/glycolide) microspheres
11/01/2005CA2115792C Method for the treatment of pain
11/01/2005CA2113242C Discharge and transfer system for apparatus for gelatin coating tablets
10/2005
10/28/2005WO2006131784A1 Body cavity foams
10/28/2005CA2565754A1 Body cavity foams
10/27/2005WO2005101466A2 Methods for fabricating isolated micro- and nano- structures using soft or imprint lithography
10/27/2005WO2005100362A1 Liquid external preparation containing pranoprofen
10/27/2005WO2005099889A1 Process for producing hollow nanoparticle with use of liposome as template
10/27/2005WO2005099787A1 Coating compositions for bioactive agents
10/27/2005WO2005099786A1 Coating compositions for bioactive agents
10/27/2005WO2005099767A1 Use of glycerol dipalmitostearate for improving the bioavailability of protein active ingredients in subcutaneous or intramuscular injectable formulations
10/27/2005WO2005099766A1 Crosslinkable pressure-sensitive adhesive for the skin
10/27/2005WO2005099765A1 Liquid composition and process for producing the same
10/27/2005WO2005099764A1 Antifungal composition for external use
10/27/2005WO2005099763A2 Composition for intracellular transfer of a nucleic acid
10/27/2005WO2005099762A1 Method for encapsulation of orally ingested materials to alter the site of digestion, site of action, or stability
10/27/2005WO2005099761A1 Dietary supplement and method of processing same
10/27/2005WO2005099760A1 Solid pharmaceutical preparation
10/27/2005WO2005099751A2 Apparatus and method for transdermal delivery of influenza vaccine
10/27/2005WO2005099732A1 Process for producing granule containing plant extract
10/27/2005WO2005099728A1 Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use
10/27/2005WO2005099718A1 Lung surfactant supplements
10/27/2005WO2005099713A2 Novel antiviral pharmaceutical composition
10/27/2005WO2005099708A1 Composition comprising itraconazole for oral administration
10/27/2005WO2005099698A1 STABILIZED 4-AMINO-5-CHLORO-N-[(1R,3r,5S)-8-METHYL-8- AZABICYCLO[3.2.1]OCT-3-YL]-2-[1-METHYLBUT-2-YNYLOXY]-BENZAMIDE CONTAINING COMPOSITION
10/27/2005WO2005099694A1 Combination of a heterocyclic compound and an antioxidant and use thereof for treating obesity
10/27/2005WO2005099685A1 Liquid external preparation containing sodium cromoglycate
10/27/2005WO2005099683A1 Antibacterial agent whose active ingredint is methyl paraoxybenzoate and composition for external application containing the same
10/27/2005WO2005099681A1 Tablet containing branched chain amino acid and process for producing the same
10/27/2005WO2005099677A1 Bazedoxifene acetate solid dispersion formulations
10/27/2005WO2005099676A2 Transdermal delivery system for use with basic permeation enhancers
10/27/2005WO2005099675A2 Sunscreen compositions with spf enhancer
10/27/2005WO2005099674A1 Pharmaceutical compositions comprising an amphiphilic starch
10/27/2005WO2005099673A1 Polycylic thiazoles as potassium ion channel modulators
10/27/2005WO2005099672A1 A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
10/27/2005WO2005099671A2 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/27/2005WO2005099670A1 Method for administering medicaments to subjects with swallowing difficulties and disorders
10/27/2005WO2005099669A1 Liquids containing suspended glass particles
10/27/2005WO2005099668A2 Methods of manufacture and use of calcium phosphate particles containing allergens
10/27/2005WO2005099667A2 Drug delivery compositions
10/27/2005WO2005099666A2 Delayed release formulations of 6-mercaptopurine
10/27/2005WO2005099665A2 Imroved formulations of 6-mercaptopurine
10/27/2005WO2005099569A1 Article and method for applying a coupling agent for a non-invasive optical probe
10/27/2005WO2005065685A8 Controlled release pharmaceutical composition comprising an acid-insoluble polymer and a bioadhesive polymer
10/27/2005WO2005065645A3 Donepezil formulations
10/27/2005WO2005065602A3 Drug delivery device with mechanical locking mechanism
10/27/2005WO2005051902A3 Modified mscl protein channel
10/27/2005WO2005051451A8 Electrical devices and anti-scarring agents
10/27/2005WO2005051353A3 Pharmaceutical formulations comprising voriconazole
10/27/2005WO2005046649A3 Multilayer pharmaceutical dosage form containing a substance that acts in a modulatory manner with regard to the release of active substances
10/27/2005WO2005046567B1 Synergistic formulation of antioxidants and antimycobacterial agents: a method of making the same
10/27/2005WO2005034972A3 Use of pharmaceutical compositions containing evening primrose oil for the treatment of xerostomia
10/27/2005WO2005027852A3 Compositions of polyacids and polyethers and methods for their use in reducing pain
10/27/2005WO2005011567A3 Foam carrier containing amphiphilic copolymeric gelling agent
10/27/2005WO2005009225A3 Tissue adhesive sealant
10/27/2005WO2004075854A3 Microbicidal compositions and method of use
10/27/2005WO2004047797A8 Crystallization method and apparatus using an impinging plate assembly
10/27/2005US20050240544 System and method for automatic generation of a hierarchical tree network and the use of two complementary learning algorithms, optimized for each leaf of the hierarchical tree network